0001493152-24-010734.txt : 20240321
0001493152-24-010734.hdr.sgml : 20240321
20240321083028
ACCESSION NUMBER: 0001493152-24-010734
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240320
FILED AS OF DATE: 20240321
DATE AS OF CHANGE: 20240321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carey Robert
CENTRAL INDEX KEY: 0001602064
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 24769576
MAIL ADDRESS:
STREET 1: HORIZON PHARMA, INC.
STREET 2: 520 LAKE COOK ROAD, SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 900 STEWART AVENUE
STREET 2: SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 900 STEWART AVENUE
STREET 2: SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4
1
ownership.xml
X0508
4
2024-03-20
0
0001641631
Beyond Air, Inc.
XAIR
0001602064
Carey Robert
C/O BEYOND AIR, INC.
900 STEWART AVENUE, SUITE 301
GARDEN CITY
NY
11530
1
0
0
0
0
Common Stock
2024-03-20
4
A
0
602410
1.66
A
2976864
D
Warrants (right to buy)
2.25
2024-03-20
4
A
0
602410
0
A
2024-03-22
2027-03-22
Common Stock
602410
602410
D
Represents the common stock of Beyond Air, Inc. acquired by the reporting person in a registered direct offering on March 20, 2024, at a price of $1.66 per share.
Represents the warrants of Beyond Air, Inc. acquired by the reporting person in a registered direct offering on March 20, 2024. The warrants will be exercisable immediately upon issuance, at an exercise price of $2.25 per share and will have a term of three years following the date of issuance.
/s/ Robert Carey
2024-03-21